Wegovy in Austin: the semaglutide product for weight management
Novo Nordisk markets semaglutide under two names. Wegovy is the brand approved for weight management at higher doses. Ozempic is approved for type 2 diabetes. Same molecule, different indication, which matters for coverage and prescribing.
The active ingredient is semaglutide in both brands
Wegovy and Ozempic both contain semaglutide, a GLP-1 receptor agonist. The difference lies in regulatory approval: Wegovy is licensed for weight management and uses higher doses, while Ozempic is licensed for type 2 diabetes at lower doses. This distinction affects which product a clinician can prescribe for your situation and which insurance plans will cover it.
Understanding this matters because some plans cover one product but not the other, even though the molecule is identical. The choice between them depends on your diagnosis and your coverage. Learn more about semaglutide, how dosing works, and insurance coverage for weight management.
Brand vs molecule
How it is prescribed
How Wegovy is prescribed and titrated
Assessment
BMI, conditions, family history and current medications. The thresholds are BMI 30, or 27 with a documented weight-related condition.
Starting dose
The lowest dose for the first four weeks. This is about tolerance rather than effect and it is not skipped.
Monthly steps
Increases at roughly four-week intervals, each conditional on the last being tolerated.
Maintenance
The dose that holds the effect and that you can stay on, which is not always the top of the range.
Approval
What regulatory approval for weight actually means
When a medication is approved for a specific indication, it means a regulator reviewed clinical trial data for that use and licensed the product at those doses. Approval is not a marketing claim; it is a legal designation that affects prescribing rights and insurance coverage decisions. Most drug plans check the approved indication before deciding whether to fund a prescription.
This is why the distinction between Wegovy and Ozempic matters in practice. A clinician can prescribe either for weight management, but insurance coverage depends on which product is approved for that indication in your jurisdiction. Before starting, we review your coverage options and which product makes sense for your situation. See coverage eligibility, medication pricing, and qualification requirements.
semaglutideMolecule
Weight managementApproved for
Weekly injectionFormat
Related
Related weight loss medication pages
The molecule it contains, the other brand of it, and the alternative.
What is in it, how it differs from Ozempic, and what it costs.
Both contain semaglutide. Wegovy is approved for weight management and titrates to higher doses; Ozempic is approved for type 2 diabetes. Same molecule, different licensed use and dose range.
No. Public health insurance does not fund GLP-1 medication prescribed for weight management. Some private and workplace plans do, usually with prior authorisation.
Appetite usually changes within the first few weeks. Meaningful weight change generally takes a couple of months, because the opening doses are about tolerance.
Digestive: nausea, fullness, constipation and reflux, generally worst in the days after a dose increase and easing as the body adjusts.
No. It is prescription-only and requires an assessment by a licensed clinician. Anyone offering it without one is not doing this properly.
I had spent months confused about which of the two names I needed. Ten minutes here sorted it out and the prescription matched what I was actually treating.
H. Bergqvist
Weight management, Austin
★★★★
Prior authorisation was refused first time. They helped with the appeal wording and the second attempt went through.
N. Oyelaran
Coverage, Cedar Park
★★★★★
Four weeks at each step, no exceptions. Slower than I wanted at the time and clearly correct in hindsight.
T. Kimura
Titration, Leander
★★★★★
The nausea in week five was real but it passed in about ten days exactly as described.
G. Almeida
Side effects, Pflugerville
From the blog
Semaglutide guides: dosing, coverage and side effects
